Rizatriptan benzoate

What is Rizatriptan benzoate?

Rizatriptan (trade name Maxalt) is a 5-HT1 receptor agonist of the triptan class of drugs developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT).

Maxalt obtained approval by the United States Food and Drug Administration (FDA) on June 29, 1998. It is a second-generation triptan.

Rizatriptan is available only by prescription in Australia, Finland, the United States, Canada and New Zealand. Similarly, it is classed as a POM (Prescription Only Medicine) in the United Kingdom, Italy (as Rizaliv), Israel (as Rizalt), The Netherlands, Croatia and Spain (as Maxalt).

Questions and answers on "Rizatriptan benzoate"

I am 54YO otherwise healthy WF w hx of Migraine HA since 20ish. Taking Maxalt 10mg and works well but my family practice physician believes I have...

doctor1 MD

Hello and thank you for sending your question.

Your question is a good one and I will work on providing you with some information and...

Read Full Thread   Ask a Doctor Now

I get migraines with aura - visual disturbances that render me unable to read. I sometimes am unable to speak clearly and sometimes my left hand...

doctor1 MD

Brief Answer:
Hemiplegic migraine.

Detailed Answer:
Hello and thanks for using HCM.

I have read your question and understand your concerns....

Read Full Thread   Ask a Doctor Now

Recent questions on Rizatriptan benzoate

Ask Question
Doctor Image

Hi, I am Dr. Andrew Rynne (Family Physician). I will be guiding you through the process. Please write your question below.

Related Drugs/Medications
Related Lab Tests
Related Procedures